Top 10 Railroad Stocks To Watch Right Now

On this day in economic and business history ...

The Dow Jones Industrial Average (DJINDICES: ^DJI  ) was first published on May 26, 1896. Charles Dow, working in partnership with Edward Jones and Charles Bergstresser, was a pioneering financial journalist who began creating stock indexes (primarily composed of railroad companies) in 1884 to flesh out his daily news bulletins. These quick briefs would be hand-delivered to traders on the New York exchange floor throughout the day and would later be aggregated into a close-of-business news recap called the "Customer's Afternoon Letter" -- the progenitor of The Wall Street Journal, which was originally only four pages long and cost its stock-loving readers a mere two cents.

Charles Dow's early forays into stock indexing coincided with a massive boom in railroad investments, an echo of the explosion of railroad companies that followed the construction and completion of the Transcontinental Railroad. However, a massive financial panic struck in 1893, crushing many railroads and causing a multiyear recession. Three years later, Dow created his first "Industrial Average," which contained only one railroad company -- and this company was actually a diversified materials enterprise as well. The Dow Jones Industrials became a symbol of American business durability while also showing the ability to adapt when necessary.

5 Best Blue Chip Stocks For 2015: Alamos Gold Inc (AGI)

Alamos Gold Inc. is engaged in the acquisition, exploration, development and extraction of precious metals in Mexico and Turkey. It owns and operates the Mulatos mine (Mulatos or the Mine) and holds the mineral rights to the Salamandra group of concessions in the State of Sonora, Mexico. The Mulatos mine is approximately 220 kilometers by air east of the City of Hermosillo. In addition, the Company owns the Agi Dagi and Kirazli advanced-stage gold development projects located in the Biga Peninsula of northwestern Turkey. Agi Dagi is located about 50 kilometers southeast of Canakkale, and Kirazli is located approximately 25 kilometers northwest of Agi Dagi. In January 2013, it acquired 14.3% interest of Aurizon Mines Ltd. (Aurizon). In August 2013, the Company acquired Esperanza Resources Corp. In September 2013, the Company announced that it has completed the acquisition of Orsa Ventures Corp. Advisors' Opinion:

• [By Jon C. Ogg]

  Alamos�Gold Inc. (NYSE: AGI) was reinstated as Buy with a target price of $21 in Canada, which would translate to closer to $20 in U.S. share prices (versus $16.33 current), at BofA/Merrill Lynch.

Top 10 Railroad Stocks To Watch Right Now: NewLead Holdings Ltd.(NEWL)

NewLead Holdings Ltd. operates as an international shipping company that owns and operates product tankers and dry bulk carriers. It operates in two segments, Wet Operations and Dry Operations. The Wet Operations segment transports various refined petroleum products simultaneously in segregated coated cargo tanks that include gasoline, jet fuel, kerosene, naphtha, and gas oil. The Dry Operations segment involves in transporting and handling bulk cargoes through ownership, operation, and trading of vessels. As of August 2, 2011, the company operated a fleet of 6 double-hull product tankers and 16 dry bulk vessels. The company was formerly known as Aries Maritime Transport Limited and changed its name to NewLead Holdings Ltd. in December 2009. NewLead Holdings Ltd. was incorporated in 2005 and is based in Athens, Greece.

Advisors' Opinion:

• [By James E. Brumley]

  October wasn't an easy month to own FreeSeas Inc. (NASDAQ:FREE), NewLead Holdings Ltd (NASDAQ:NEWL), DryShips Inc. (NASDAQ:DRYS), or any maritime shipper for that matter. They were all down rather sharply after heroic runups in September. DRYS fell 22% last month. NEWL slumped 41% in October. FREE gave up 44% of its value last month. What happened? After all, these same stocks were among some of the hottest names in September. In simplest terms, what happened here is what happens all too often... the market "got it right" in terms of the premise, but overdid it. Now that the dust is settling though, the undertow is kicking in again, but this time at a more reasonable/sustainable pace.

Top 10 Railroad Stocks To Watch Right Now: Gray Fox Petroleum Corp (GFOX)

Gray Fox Petroleum Corp., incorporated on September 22, 2011, is a domestic oil and gas exploration and development company. The Company focuses on the acquisition and exploration of oil and natural gas properties in the Western United States.

The Company has 100% working interest and an 82% net revenue interest in the 32,723 acre West Ranch Prospect. The Company�� West Ranch Prospect is located in the Butte Valley Oil Play Region of north central Nevada in Elko and White Pine Countries, which has produced over 50 million barrels of oil in Nevada from structures and reservoir horizons similar to those under the West Ranch Prospect. The prospect consists of 22 Federal leases in the Butte Valley Oil Play Region.

Advisors' Opinion:

• [By Peter Graham]

  On Friday, small cap mining stocks Maverick Minerals Corp (OTCMKTS: MVRM) and Liberty Coal Energy Corp (OTCMKTS: LBTG) plus oil stock Gray Fox Petroleum Corp (OTCBB: GFOX) sank 30.9%, 16.67% and 11.2%, respectively. However, only one of these stocks appears to have been the subject of some kind of paid promotion in the form of an investment in some shares. So will these three small cap mining or oil stocks keep coming up empty for investors this week? Here is a closer look:

Top 10 Railroad Stocks To Watch Right Now: National Health Investors Inc. (NHI)

National Health Investors, Inc., a real estate investment trust (REIT), invests in health care properties, primarily in the long-term care industry in the United States. As of December 31, 2008, it had investments in real estate assets and mortgage notes receivable investments in 123 health care facilities consisting of 83 long-term care facilities, 1 acute care hospital, 4 medical office buildings, 14 assisted living facilities, 4 retirement centers, and 17 residential projects for the developmentally disabled in 17 states. The company has elected to be treated as a REIT for federal income tax purposes and would not be subject to federal income tax, if it distributes at least 90% of its REIT taxable income to its shareholders. National Health Investors, Inc. was founded in 1991 and is based in Murfreesboro, Tennessee.

Advisors' Opinion:

• [By Lauren Pollock]

  National Health Investors Inc.(NHI) signed an agreement to acquire 25 independent-living facilities from Holiday Retirement Corp. affiliates for $491 million. The health-care focused real-estate investment trust also unveiled plans to offer 4.5 million shares of its stock to help fund the pending deal.

• [By Jonas Elmerraji]

   

   

  After performing pretty poorly in the last year, $2 billion healthcare property owner National Health Investors (NHI) has gone from laggard to leader in 2014. Since the start of the year, NHI has moved more than 11% higher, stomping the S&P 500's performance by comparison. And now, NHI looks well positioned for another leg up...

   

  NHI is forming a "rounding bottom" pattern, a basic classic setup that looks exactly like it sounds: it's identified by a curved support level below shares and a horizontal resistance level to the top side. That rounded support line indicates a gradual shift in control from sellers to buyers -- and resistance at $63 is the price level to watch from here.

   

  Why all the significance at $63? It all comes down to buyers and sellers. Price patterns are a good quick way to identify what's going on in the price action, but they're not the reason a stock is tradable. Instead, the "why" comes down to basic supply and demand for NHI's stock.

   

  The $63 resistance level is a price where there has been an excess of supply of shares; in other words, it's a spot where sellers have previously been more eager to step in and take gains than buyers have been to buy. That's what makes a breakout above $63 so significant -- the move means that buyers are finally strong enough to absorb all of the excess supply above that price level.

   

• [By Marc Bastow]

  Long-term care and senior housing real estate investment trust National Health Investors (NHI) raised its quarterly dividend 6.2% to 77 cents per share, payable on May 9 to shareholders of record as of Mar. 31. NHI stock has the second-highest yield on this week’s list of dividend stocks increasing payouts.
  NHI Dividend Yield: 4.88%

Top 10 Railroad Stocks To Watch Right Now: DXP Enterprises Inc.(DXPE)

DXP Enterprises, Inc. engages in distributing maintenance, repair, and operating (MRO) products, equipment, and services to industrial customers in the United States. Its Service Centers segment provides MRO products, equipment and services, including technical design expertise and logistics capabilities to industrial customers with the ability to provide same day delivery. This segment?s product categories comprise rotating equipment, bearing, power transmission, hose, fluid power, metal working, industrial supply, and safety products; and services consist of field safety supervision, in-house and field repair, and maintenance services. The company?s Supply Chain Services segment manages the supply-chain of its customers from various industries. This segment designs supply chain inventory management programs, including SmartAgreement, a procurement solution for MRO categories; SmartBuy, an on-site or centralized MRO procurement solution; SmartSource, an on-site procurem ent and storeroom management solutions; SmartStore, an e-catalog solution; SmartVend, an industrial dispensing solution; and SmartServ, an integrated service pump solution. Its Innovative Pumping Solutions segment fabricates and assembles custom-made engineered pump packages consisting of diesel and electric driven firewater, pipeline booster, potable water packages, pigging pump packages, LACT charge units, chemical injection pump packages wash down units, seawater lift pumps, jockey pumps, condensate pump packages, cooling water skids, and seawater/produced water injection packages. DXP Enterprises, Inc. distributes its products and services through service centers and distribution centers to customers in the oil and gas, food and beverage, petrochemical, transportation, mining, construction, chemical, municipal, agriculture, pulp and paper, and other general industrial industries. The company was founded in 1908 and is headquartered in Houston, Texas.

Advisors' Opinion:

• [By Rich Smith]

  Houston-based DXP Enterprises (NASDAQ: DXPE  ) has purchased Canada's National Process Equipment, also known as Natpro, the company announced Wednesday. In so doing, DXP expanded its industrial equipment wholesaling business to include Natpro's portfolio of pumps, integrated system packaging, compressors, and related equipment.

• [By Seth Jayson]

  Margins matter. The more DXP Enterprises (Nasdaq: DXPE  ) keeps of each buck it earns in revenue, the more money it has to invest in growth, fund new strategic plans, or (gasp!) distribute to shareholders. Healthy margins often separate pretenders from the best stocks in the market. That's why we check up on margins at least once a quarter in this series. I'm looking for the absolute numbers, so I can compare them to current and potential competitors, and any trend that may tell me how strong DXP Enterprises's competitive position could be.

• [By Eric Volkman]

  The position vacated by Salix in the S&P SmallCap 600 will be filled by Agree Realty (NYSE: ADC  ) . Elsewhere on that index, DXP Enterprises (NASDAQ: DXPE  ) �will replace True Religion Apparel (NASDAQ: TRLG  ) . As with Gardner Denver in the S&P MidCap 400, True Religion Apparel is being acquired, in this case by private equity firm TowerBrook Capital Partners.

• [By Lisa Levin]

  DXP Enterprises (NASDAQ: DXPE) shares climbed 3.46% to $68.42. The volume of DXP Enterprises shares traded was 771% higher than normal. DXP Enterprises' PEG ratio is 0.64.

Top 10 Railroad Stocks To Watch Right Now: Agenus Inc.(AGEN)

Agenus Inc., a biotechnology company, engages in developing and commercializing technologies to treat cancers and infectious diseases. It offers Oncophage vaccine for the treatment of adjuvant renal cell carcinoma. The company?s products under development include Prophage series of cancer vaccines, which has been tested in Phase III clinical trials for the treatment of renal cell carcinoma (RCC) and metastatic melanoma, as well as has been tested in Phase I and Phase II clinical trials in various indications; and under Phase II clinical trials in glioma, a type of brain cancer, and adjuvant renal cell carcinoma. The Prophage series of cancer vaccines include R-series candidates in RCC, M-series candidates in melanoma, and G-series candidates in glioma. Its product candidate portfolio includes QS-21 Stimulon adjuvant, which is in Phase III clinical trials for the treatment of non-small cell lung cancer, melanoma, malaria, and shingles, as well as in for the treatment of va rious infectious diseases and Alzheimer?s disease; and HerpV that completed Phase 1 clinical trial for the treatment of genital herpes. The company was formerly known as Antigenics Inc. and changed its name Agenus Inc. in January 2011 to reflect its existing product pipeline. Agenus Inc. was founded in 1994 and is headquartered in Lexington, Massachusetts.

Advisors' Opinion:

• [By John Udovich]
  Follow-on Stock Offerings From Small Cap Biotech Stocks. Thanks to the boom in biotech IPOs along with the sector�� overall performance, already listed biotechs have the option to ask investors for more cash in the form of a follow-on offering. Recently, FierceBiotech.com noted how four small cap biotechs raised $276 million from follow-on offerings in just one day last week. These small caps�included Epizyme Inc (NASDAQ: EPZM) which raised $88 million, Halozyme Therapeutics, Inc (NASDAQ: HALO) which raised $100 million, Agenus Inc (NASDAQ: AGEN) which raised $52 million and Idera Pharmaceuticals Inc (NASDAQ: IDRA) which raised $36 million. FierceBiotech.com noted that the�steady flow of about $4.5 billion a year in venture cash�along with�more than $3.5 billion from IPOs last year plus all of the�follow-ons are helping to foster both company growth and�accelerate drug�development programs. Mixed Bag for Biotech IPOs. Last Wednesday also saw two small cap biotech IPOs fizzle in one day�with small cap T cell vaccine developer�Genocea Biosciences Inc (NASDAQ: GNCA) raising $60 million but then ending the day down 8.3% to close at $11 while Dutch drug developer uniQure NV (QURE) raised $81.9 million but fell more than 14% to $14.61. However, orphan drug stock Auspex Pharmaceuticals Inc (NASDAQ: ASPX), which is developing�drugs to treat orphan diseases like Tourette syndrome, saw a 30.5% gain to close at $15.66 and raise $84 million. The Boston Globe quoted Michael Ringel, a partner and managing director at Boston Consulting Group who focuses on health care business, as saying:

  ��he mood is incredibly positive. Capital is flowing. [The biotech IPOs]��have been burning hot. I think it�� too early to suggest that is changing. I can�� predict the overall economy any better than anyone else, but I would expect a pretty good year for IPOs.��/p>

• [By Monica Gerson]

  © 2014 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

    Most Popular Are Massive Xbox One 'Titanfall' Sales To Blame For Xbox 360 Game Delay? Warren Buffett's Conflicting Bitcoin Views Marijuana Econom
• [By Smith On Stocks]

  I am initiating coverage of Agenus (AGEN) with a Buy. I have just published a basic report on my website, which goes into detail on the company's two core technology platforms: (1) the heat shock protein technology that is the basis of therapeutic and preventive vaccines for cancer and infectious disease, and (2) the QS-21 Stimulon adjuvant that is being used by Agenus and other vaccine developers to enhance the effectiveness of their vaccines. This report is a summary of that more detailed report.

Top 10 Railroad Stocks To Watch Right Now: Orbital Sciences Corporation(ORB)

Orbital Sciences Corporation develops and manufactures small and medium-class rockets and space systems for commercial, military, and civil government customers. The company operates in three segments: Launch Vehicles, Satellites and Space Systems, and Advanced Space Programs. The Launch Vehicles segment develops and produces small-class launch vehicles that place satellites into low-Earth orbit; interceptor launch vehicles for missile defense systems, including interceptor boosters; and target launch vehicles, such as suborbital rockets and their principal subsystems, as well as payloads carried by vehicles used in the development and testing of missile defense systems. The Satellites and Space Systems segment develops and produces communications satellites that provide cable and direct-to-home television distribution, business data network connectivity, regional mobile telephony, and other space-based communications services; and science and remote sensing satellites tha t are used to conduct space-related scientific research, collect imagery and other remotely-sensed data about the Earth, carry out interplanetary and other deep-space exploration missions, and demonstrate new space technologies. This segment also provides space systems and subsystems, including satellite command and data handling, and attitude control and structural subsystems; and a range of space-related technical services, including analytical, engineering, and production services for space-related science and defense programs. The Advanced Space Programs segment develops and produces human-rated systems to be used in earth orbit, planetary exploration, and other space missions; and small and medium-class satellites and related systems used primarily for national security space missions and related technology demonstration programs. It operates in the United States, Europe, Mexico, South America, Australia, and east Asia. The company was founded in 1982 and is headquarter ed in Dulles, Virginia.

Advisors' Opinion:

• [By Quick Pen]

  The aerospace sector is increasingly becoming competitive. The acquisition proposal comes at a time when another Dulles-based industry player Orbital Sciences (ORB) plans to combine with the defense segment of Alliant Techsystems��(ATK) and emerge as a stronger new entity named Orbital ATK. The defense space has been vastly dominated by the United Launch Alliance, which is a joint venture between Chicago-based aircraft major Boeing (BA) and Lockheed Martin. However, after the $5 billion merger deal to form Orbital ATK is complete, the industry will grow more competitive.

• [By Jake L'Ecuyer]

  Shares of Orbital Sciences (NYSE: ORB) got a boost, shooting up 15.38 percent to $30.66 after the company and Allian Techsystems' (NYSE: ATK) Aerospace and Defense Groups agreed to combine to create Orbital ATK.

• [By Chris Katje]

  For those unfamiliar with Orbital Sciences (ORB), the company is a leader in space missions and satellite services. The company operates its business in three segments: launch vehicles, satellites and space systems, and advanced space programs. The company's contract with the International Space System, huge backlog, and human space exploration could send shares much higher than current levels.